Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
INDIA – Sun Pharma announced that it has entered into a unique patent licensing agreement with Danish drugmaker Lundbeck to market and distribute its own brand of antidepressant medicine Vortioxetine…
Read More
INDIA – Sun Pharmaceutical Industries announced on Monday that it has entered into a share purchase agreement with Daiichi Sankyo Company of Japan to acquire the latter’s 11.28 percent stake…
Read More
INDIA – Sun Pharma, India’s giant drugmaker, the company is looking for possible in-licensing opportunities and even acquisitions to bolster its global specialty business, Economic Times reports, citing the company’s…
Read More
INDIA – Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)…
Read More
USA – A Boston federal judge has ruled that Sun Pharmaceutical Industries Ltd. must face a multidistrict lawsuit over its alleged scheme to corner the market for generic versions of…
Read More
INDIA – Sun Pharmaceutical Industries, a leading pharmaceutical manufacturer in India, is gearing up to introduce Merck Sharpe Dohme and Ridgeback’s molnupiravir under the brand name Molxvir. The Drugs Controller…
Read More
INDIA – Indian antiviral manufacturers are becoming increasingly important as the first-ever COVID-19 oral treatment Molnupiravir is introduced, promising to hasten the world’s recovery from the coronavirus pandemic. Molnupiravir reduces…
Read More
INDIA – Sun Pharma has launched a novel formulation antitussive syrup, Chericof 12 manufactured using Polistirex technology for sustained drug release. The syrup is the first prescription cough syrup that…
Read More
INDIA – Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Limited, has announced its foray into the nutrition bar segment in India with the launch of Revital NXT.…
Read More
US – The National Institute of Allergy and Infectious Diseases’ (NIAID) phase 1 clinical trials of its malaria vaccine, Sanaria (PfSPZ), have found that the regimen conferred unprecedentedly high levels…
Read More